All In Biotech

Free tool

FAERS Monitor: Vafseo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215192 or its brand name (Vafseo, Vadadustat). Reports on generic versions are filed under their own applications.

Reports

307

Serious

267

87% of reports

Hospitalization

108

Death reported

96

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea30
  • haemoglobin decreased20
  • off label use20
  • death17
  • cardiac failure14
  • marasmus14
  • nausea13
  • drug interaction12
  • pneumonia11
  • cardiac failure congestive9
  • haemoglobin increased9
  • rhabdomyolysis9
  • cardiac failure chronic8
  • dialysis8
  • pneumonia aspiration8

Reports by year received

View as table
YearReports
20191
20206
20212
202214
202327
2024133
202555
202669

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,852 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
marasmusSignal14637.1381.08,191
haemoglobin increasedSignal9135.471.11,068
cardiac failure chronicSignal8128.865.0890
dialysisSignal838.619.5257
pneumonia aspirationSignal821.911.1140
rhabdomyolysisSignal914.87.8103
haemoglobin decreasedSignal2013.38.7217
cardiac failureSignal1411.97.2130
cardiac failure congestiveSignal97.74.046
drug interactionSignal125.23.037
diarrhoeaSignal303.22.344
pneumoniaSignal112.31.37
off label use201.61.04
death171.40.91
nausea131.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.